DSIJ Mindshare

The following stocks will be in focus during Tuesday’s trading session in light of their results announcements: Dabur, NCC, Titan, Ajanta Pharma and Divi’s Labs.

In the last trading sessions, the BSE Sensex recorded a fresh all-time high, whereas, the Nifty attempted to reclaim the magical figure of 12,000 mark. However, the 12,000 mark on the Nifty remained a far-fetched dream. In the overnight trade on Wall Street, all three major indices touched record highs but there is not much from Asian peers to drive the market today.

Hikal Limited announced having received the Establishment Inspection Report (EIR) from the United States Food and Drug Administration (USFDA) for its Active Pharmaceutical Ingredient (API) unit located in Bangalore.

Bharat Heavy Electricals Ltd (BHEL) won an order for renovation, modernisation and uprating (RM&U) of the Chilla Hydro Electric Plant (HEP) from Uttarakhand Jal Vidyut Nigam Ltd (UJVNL). The project is valued at over Rs. 200 crore.

On the downside, the immediate supports are seen around 29890-29630 levels as it is the confluence of 8-day EMA and 13-day EMA. On the upside, the Bank Nifty needs to sustain above the zone of 30800-30600 level to maintain its positive stance. If it is unable to surpass this level, then there are chances of the index entering a corrective to sideways phase.